![]() |
Natamycin products introduction:
NATAMYCIN (PIMARICIN) is a naturally antimycotic product which is classified as a polyene macrolide and can be produced during fermentation by the bacterium Streptomyces spp. Natamycin not only inhibits the growth of different moulds and yeasts broadly and high-effectively, but also inhibits the production of their toxin. It fully complies with the specifications laid down by the FDA and the JECFA with regard to its use on cheeses and fermented meat products.
Product list
Product |
Benefits |
Applications |
95%-natamycin |
Anti yeasts and moulds |
Bakery, Beverage, Dairy, Meat |
50%-Glucose |
Bread, Cake, Tortilla, FRUIT JUICE |
|
50%-Lactose |
Cheese |
|
50%-NaCl |
sausage |
Package 100 g/bottle, 500g/bottle, 1kg/bottle, 1kg/bag, 20kg/barrel or as customers’ requirements.
Shandong Freda Biotechnology Co., Ltd. is a high-tech biotechnology enterprise co-founded by Shandong
Freda Pharmaceutical Group Corporation, Shandong Business Group, and Shandong High-tech Investment
Co., Ltd. The company's registered capital is RMB 71.4 million. It focuses mainly on the R & D, manufacture
and sales of green food additives ,cosmetics as well as crude drug products, such as biological polysaccharides,
preservatives, and macromolecule polymers.Currently the main products are Natamycin, Nisin, Pullulan,
Poly Glutamic Acid and pharmaceutical Xanthan gum.
The company has established a modern industrial base in Shandong Linshu Economic Development Zone, occupying
about 36 acres. The company is equipped with advanced biological fermentation, biochemical extraction, purification
and refining equipment. The air purification system of the facility guarantees that the manufacturing environment strictly
complies with GMP standards. The world-class detection equipment and strict quality management process ensures
the quality, reliability and stability of our products.
The company collaborates with Biotechnological Technology Center of Shandong Pharmaceutical Academy, which
serves as its R & D platform and employs eight Ph.D.s and twentyeight Masters in the specified research areas. With
years of development and management, it has established a platform for microbial strain screening,microbial fermentation,
genetic engineering,and macrobiomolecule separation and purification. A number of microbial fermentation products have
been successfully developed and manufactured in industry scale in recent five yearsmore
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |